Pharmafile Logo
Pharmafocus logo
Advanced Search

Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration

April 4, 2023
Business Services

Brighton, United Kingdom – 4 April 2023 – Destiny Pharma (AIM: DEST), a clinical stage innovative biotechnology company focused on …

News
Press release

PHARMANOVIA RECEIVES SBTi APPROVAL FOR NET ZERO EMISSION TARGETS

April 4, 2023
Business Services

Basildon, UK, 3 April 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already established …

News
Press release
steve_jones_chief_financial_officer_for_ingenza

Ingenza appoints Steve Jones as its new Chief Financial Officer

April 4, 2023
Business Services Ingenza

  Ingenza appoints Steve Jones as its new Chief Financial Officer  

Appointment

Orbit Discovery and Evergreen Discovery collaborate to discover peptides for targeting radiopharmaceuticals

April 4, 2023
Business Services

New Jersey, USA, and Oxford, UK, 3rd April 2023: Evergreen Discovery (Evergreen), a leading radiopharmaceutical drug development company with a …

News
Press release
brano-mm1vipqd0oa-unsplash

Vertex Pharmaceuticals and CRISPR Therapeutics submit FDA rolling Biologics License Applications for gene editing-based medicine

April 4, 2023
Research and Development

US-based Vertex Pharmaceuticals and Swiss CRISPR Therapeutics have announced the completion of their rolling Biologics License Applications (BLAs) to the …

News
towfiqu-barbhuiya-6f2mpewg2ra-unsplash

FDA publishes report stating Global Pharma’s eye drops broke safety norms

April 4, 2023
Medical Communications

The FDA has published a report revealing that Global Pharma’s plant in India’s Chennai city failed to achieve safety norms …

News
james-yarema-5tymgag0wro-unsplash_1

InnoCare announced first subject dosed in clinical trial of novel targeted protein degrader ICP-490

April 4, 2023
Medical Communications

InnoCare has announced that the first subject has been dosed in its clinical trial of its novel targeted protein degrader …

News

Merck receives FDA approval for Keytruda in combination with Padcev to treat bladder cancer

April 4, 2023
Medical Communications

Merck (known as MSD globally) has announced that it has received FDA approval for Keytruda in combination with Padcev for …

News

Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101

April 3, 2023
Sales and Marketing

Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …

News
ed-us-k0dml4nmopo-unsplash

aVaxziPen announces positive data for multiple diseases with novel needle-free vaccine

April 3, 2023
Research and Development

aVaxziPen, a biotech company focusing on the development of a novel needle-free vaccine delivery platform, has announced that it will …

News
david-travis-avvzjc0ynbq-unsplash_1

Pixium Vision’s Prima System granted FDA Breakthrough Device Designation

April 3, 2023
Medical Communications

French bioelectronics company Pixium Vision has been granted Breakthrough Device Designation by the FDA for its Prima System.   Prima …

News
pawel-czerwinski-kxblpqfyc9e-unsplash

AstraZeneca’s NMOSD treatment recommended marketing authorisation by CHMP

April 3, 2023
Medical Communications

Pharma giant AstraZeneca has been given a recommendation by the EU’s Committee for Medicinal Products (CHMP) for marketing authorisation for …

News

CrestOptics launches CICERO system to provide all-in-one solution for widefield and spinning disk confocal microscopy

April 3, 2023
Business Services

Rome, IT, 03 April, 2023: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and …

News
Press release

Sequana Medical announces submission of Investigational New Drug (IND) application for DSR® 2.0 for treatment of congestive heart failure

April 3, 2023
Business Services

Ghent, Belgium – 03 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)

April 3, 2023
Business Services

Lack of access to qualified health personnel combined with an alarming prevalence of noncommunicable diseases (NCDs) such as cardiometabolic diseases …

News
Press release

Redx Confirms Proposed Business Combination with Jounce has Formally Lapsed

April 3, 2023
Business Services

Alderley Park, UK, 3 April 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis

March 31, 2023
Business Services Almirall, Dermatology, dermatology, lebrikizumab

BARCELONA, Spain. March 31, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the …

News
Press release

HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer

March 31, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Friday, March 31, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces that …

News
Press release

Abbott gains FDA approval for Epic Max tissue valve for the treatment of aortic valve disease

March 31, 2023
Medical Communications

Abbott has announced that the FDA has approved its Epic Max stented tissue valve to treat patients with aortic regurgitation …

News

First over-the-counter opioid overdose treatment approved by FDA

March 31, 2023
Medical Communications

The FDA has announced that it has approve Narcan, 4mg naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription use. This …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026